168 related articles for article (PubMed ID: 9639082)
1. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
Go FS; Malley EE; Birmaher B; Rosenberg DR
J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
[TBL] [Abstract][Full Text] [Related]
2. Obsessive compulsive disorder, depression, and fluoxetine.
Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of obsessive compulsive disorder.
Goodman WK; McDougle CJ; Price LH
J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
[TBL] [Abstract][Full Text] [Related]
4. Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability.
Levy DM; Arush OB; Carmi L; Wetzler AJ; Zohar J
Compr Psychiatry; 2024 Aug; 133():152486. PubMed ID: 38703743
[TBL] [Abstract][Full Text] [Related]
5. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
Tollefson GD; Birkett M; Koran L; Genduso L
J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
[TBL] [Abstract][Full Text] [Related]
6. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
[TBL] [Abstract][Full Text] [Related]
7. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
[TBL] [Abstract][Full Text] [Related]
8. The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: preliminary clinical experience.
Eapen V; Trimble MR; Robertson MM
Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):737-43. PubMed ID: 8843495
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience.
Riddle MA; Hardin MT; King R; Scahill L; Woolston JL
J Am Acad Child Adolesc Psychiatry; 1990 Jan; 29(1):45-8. PubMed ID: 2295577
[TBL] [Abstract][Full Text] [Related]
10. An open trial and discontinuation study of fluoxetine in children and adolescents with obsessive-compulsive disorder.
Semerci ZB; Unal F
Turk J Pediatr; 2001; 43(4):323-8. PubMed ID: 11765163
[TBL] [Abstract][Full Text] [Related]
11. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
Simeon JG; Thatte S; Wiggins D
Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
[TBL] [Abstract][Full Text] [Related]
12. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
Etain B; Bonnet-Perrin E
Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
[TBL] [Abstract][Full Text] [Related]
13. An adolescent male with multiple paraphilias successfully treated with fluoxetine.
Galli VB; Raute NJ; McConville BJ; McElroy SL
J Child Adolesc Psychopharmacol; 1998; 8(3):195-7. PubMed ID: 9853694
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-induced mania in obsessive-compulsive disorder.
Vieta E; Bernardo M
Am J Psychiatry; 1992 Sep; 149(9):1282-3. PubMed ID: 1503154
[No Abstract] [Full Text] [Related]
15. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder.
Geller DA; Biederman J; Reed ED; Spencer T; Wilens TE
J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):36-44. PubMed ID: 7860454
[TBL] [Abstract][Full Text] [Related]
16. Mania associated with fluoxetine treatment in adolescents.
Venkataraman S; Naylor MW; King CA
J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):276-81. PubMed ID: 1564030
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant treatment-associated behavioural expression of hypomania: a case series.
Ramasubbu R
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1201-7. PubMed ID: 15610935
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
[TBL] [Abstract][Full Text] [Related]
19. Staying Up at Night: Overlapping Bipolar and Obsessive-Compulsive Disorder Symptoms in an Adolescent with Autism Spectrum Disorder.
Cawkwell P; Lawler A; Maneta E; Coffey BJ
J Child Adolesc Psychopharmacol; 2016 Feb; 26(1):74-7. PubMed ID: 26881860
[No Abstract] [Full Text] [Related]
20. Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo.
Tauscher-Wisniewski S; Nilsson M; Caldwell C; Plewes J; Allen AJ
J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):713-8. PubMed ID: 17979590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
